MBOT · Microbot Medical Inc.
Market Cap
$100.75M
Shares
67.16M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Harel Gadot | CEO, President & Chairman | $1,241,479 |
| Simon Sharon | CTO and General Manager | $539,429 |
| Juan Diaz-Cartelle | CMO | $376,478 |
| Rachel Vaknin | CFO | $363,165 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Harel Gadot | CEO, President & Chairman | $1,284,123 |
| Eyal Morag | CMO | $511,872 |
| Simon Sharon | CTO and General Manager | $469,930 |
| Rachel Vaknin | CFO | $289,503 |
| Juan Diaz-Cartelle | CMO | $15,528 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Harel Gadot | CEO, President & Chairman | $1,838,166 |
| Eyal Morag | CMO | $601,269 |
| Simon Sharon | CTO and General Manager | $526,330 |
| Rachel Vaknin | CFO | $234,647 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Harel Gadot | CEO, President & Chairman | $1,555,800 |
| Eyal Morag | CMO Rachel Vaknin | $613,059 |
| Simon Sharon | CTO and General Manager | $560,013 |
| David Ben Naim | Chief Financial Officer | $81,754 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Harel Gadot | CEO, President & Chairman | $2,356,246 |
| Simon Sharon | CTO and General Manager | $443,745 |
| Eyal Morag | Chief Medical Officer | $271,701 |
| David Ben Naim | Chief Financial Officer | $102,550 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Harel Gadot | CEO, President & Chairman | $1,000,293 |
| David Ben Naim | Chief Financial Officer | $94,576 |
| Eyal Morag | Chief Medical Officer | — |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| David J. Wilson | Class III director | Appointed | 2024-12-19 |
| Dr. Juan Diaz-Cartelle | Chief Medical Officer | Appointed | 2023-11-21 |
| Eyal Morag | Chief Medical Officer | Resigned | 2023-09-05 |
| Rachel Vaknin | Chief Financial Officer | Appointed | 2022-04-06 |
| David Ben Naim | Chief Financial Officer | Resigned | 2022-04-06 |
| Simon Sharon | General Manager of the Company's wholly-owned subsidiary, Microbot Medical Ltd. | Appointed | 2021-04-07 |
| Tal Wenderow | Class I director | Appointed | 2020-08-03 |
| Yoav Waizer | member of the Board of Directors | Resigned | 2020-06-19 |
| Dr. Eyal Morag | Chief Medical Officer | Appointed | 2020-05-07 |
| Aileen Stockburger | Class II director | Appointed | 2020-04-01 |
| Dr. Eyal Morag | Chief Medical Officer | Appointed | 2020-03-03 |
Key facts
CIK
883975
CUSIP
59503A204
13F (30d)
64 filings
58 filers
Visit website
Investor relations